{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:41:39Z","timestamp":1789087299888,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Youth Innovation Science Fund of the Chinese PLA General Hospital","award":["22QNCZ028"],"award-info":[{"award-number":["22QNCZ028"]}]},{"name":"Open Project National Clinical Research Center for Otolaryngologic Diseases","award":["202200010"],"award-info":[{"award-number":["202200010"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2501203 and 2021YFC2501206"],"award-info":[{"award-number":["2021YFC2501203 and 2021YFC2501206"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12035-024-04560-3","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T04:22:12Z","timestamp":1732335732000},"page":"5566-5578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tim-3 Deficiency Ameliorates Motor Deficits and Neuroinflammation in MPP+\/MPTP-Induced Parkinson\u2019s Disease Models via the NF-\u03baB\/NLRP3 Pathway"],"prefix":"10.1007","volume":"62","author":[{"given":"Xi","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gencheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,23]]},"reference":[{"key":"4560_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-022-00934-6","author":"HN Costa","year":"2022","unstructured":"Costa HN, Esteves AR, Empadinhas N, Cardoso SM (2022) Parkinson\u2019s Disease: a multisystem disorder. Neurosci Bull. https:\/\/doi.org\/10.1007\/s12264-022-00934-6","journal-title":"Neurosci Bull"},{"key":"4560_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris HR, Spillantini MG, Sue CM, Williams-Gray CH (2024) The pathogenesis of Parkinson\u2019s disease. Lancet Lond Engl 403:293\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(23)01478-2","journal-title":"Lancet Lond Engl"},{"key":"4560_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00281-022-00947-3","volume":"44","author":"B Zhu","year":"2022","unstructured":"Zhu B, Yin D, Zhao H, Zhang L (2022) The immunology of Parkinson\u2019s disease. Semin Immunopathol 44:659\u2013672. https:\/\/doi.org\/10.1007\/s00281-022-00947-3","journal-title":"Semin Immunopathol"},{"key":"4560_CR4","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C et al (2022) Neuroinflammation and Parkinson\u2019s Disease-from neurodegeneration to Therapeutic opportunities. Cells 11:2908. https:\/\/doi.org\/10.3390\/cells11182908","journal-title":"Cells"},{"key":"4560_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC et al (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"4560_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1042\/BJ20150617","volume":"471","author":"A Gustot","year":"2015","unstructured":"Gustot A, Gallea JI, Sarroukh R et al (2015) Amyloid fibrils are the molecular trigger of inflammation in Parkinson\u2019s disease. Biochem J 471:323\u2013333. https:\/\/doi.org\/10.1042\/BJ20150617","journal-title":"Biochem J"},{"key":"4560_CR7","doi-asserted-by":"publisher","first-page":"e2025847118","DOI":"10.1073\/pnas.2025847118","volume":"118","author":"D Trudler","year":"2021","unstructured":"Trudler D, Nazor KL, Eisele YS et al (2021) Soluble \u03b1-synuclein\u2013antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia. Proc Natl Acad Sci 118:e2025847118. https:\/\/doi.org\/10.1073\/pnas.2025847118","journal-title":"Proc Natl Acad Sci"},{"key":"4560_CR8","doi-asserted-by":"publisher","unstructured":"Brichta L, Greengard P (2014) Molecular determinants of selective dopaminergic vulnerability in Parkinson\u00e2\u20acTMs disease: an update. Front Neuroanat 8. https:\/\/doi.org\/10.3389\/fnana.2014.00152","DOI":"10.3389\/fnana.2014.00152"},{"key":"4560_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Obeso JA, Halliday GM (2017) Selective neuronal vulnerability in Parkinson disease. Nat Rev Neurosci 18:101\u2013113. https:\/\/doi.org\/10.1038\/nrn.2016.178","journal-title":"Nat Rev Neurosci"},{"key":"4560_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah4066","volume":"10","author":"R Gordon","year":"2018","unstructured":"Gordon R, Albornoz EA, Christie DC et al (2018) Inflammasome inhibition prevents \u03b1-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10:eaah4066. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","journal-title":"Sci Transl Med"},{"key":"4560_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L et al (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160:62\u201373. https:\/\/doi.org\/10.1016\/j.cell.2014.11.047","journal-title":"Cell"},{"key":"4560_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxlet.2021.05.008","volume":"349","author":"X Qiu","year":"2021","unstructured":"Qiu X, Wang Q, Hou L et al (2021) Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson\u2019s disease model. Toxicol Lett 349:1\u201311. https:\/\/doi.org\/10.1016\/j.toxlet.2021.05.008","journal-title":"Toxicol Lett"},{"key":"4560_CR13","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1084\/jem.20182191","volume":"216","author":"N Panicker","year":"2019","unstructured":"Panicker N, Sarkar S, Harischandra DS et al (2019) Fyn kinase regulates misfolded \u03b1-synuclein uptake and NLRP3 inflammasome activation in microglia. J Exp Med 216:1411\u20131430. https:\/\/doi.org\/10.1084\/jem.20182191","journal-title":"J Exp Med"},{"key":"4560_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ebiom.2019.10.036","volume":"50","author":"S Sn","year":"2019","unstructured":"Sn S, Pandurangi J, Murumalla R et al (2019) Small molecule modulator of aggrephagy regulates neuroinflammation to curb pathogenesis of neurodegeneration. EBioMedicine 50:260\u2013273. https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.036","journal-title":"EBioMedicine"},{"key":"4560_CR15","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/ni739","volume":"2","author":"JJ McIntire","year":"2001","unstructured":"McIntire JJ, Umetsu SE, Akbari O et al (2001) Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim Gene family. Nat Immunol 2:1109\u20131116. https:\/\/doi.org\/10.1038\/ni739","journal-title":"Nat Immunol"},{"key":"4560_CR16","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","volume":"20","author":"Y Wolf","year":"2020","unstructured":"Wolf Y, Anderson AC, Kuchroo VK (2020) TIM3 comes of age as an inhibitory receptor. Nat Rev Immunol 20:173\u2013185. https:\/\/doi.org\/10.1038\/s41577-019-0224-6","journal-title":"Nat Rev Immunol"},{"key":"4560_CR17","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1007\/s00262-023-03516-1","volume":"72","author":"N Sauer","year":"2023","unstructured":"Sauer N, Janicka N, Szlasa W et al (2023) TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors. Cancer Immunol Immunother CII 72:3405\u20133425. https:\/\/doi.org\/10.1007\/s00262-023-03516-1","journal-title":"Cancer Immunol Immunother CII"},{"key":"4560_CR18","doi-asserted-by":"publisher","unstructured":"Koh HS, Chang CY, Jeon SB et al (2015) The HIF-1\/glial TIM-3 axis controls inflammation-associated brain damage under hypoxia. Nat Commun 6. https:\/\/doi.org\/10.1038\/ncomms7340","DOI":"10.1038\/ncomms7340"},{"key":"4560_CR19","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.euroneuro.2016.10.003","volume":"26","author":"E Kossatz","year":"2016","unstructured":"Kossatz E, Maldonado R, Robledo P (2016) CB2 cannabinoid receptors modulate HIF-1\u03b1 and TIM-3 expression in a hypoxia-ischemia mouse model. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26:1972\u20131988. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.10.003","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"4560_CR20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/cns.13100","volume":"25","author":"Z-Q Chen","year":"2019","unstructured":"Chen Z-Q, Yu H, Li H-Y et al (2019) Negative regulation of glial Tim-3 inhibits the secretion of inflammatory factors and modulates microglia to antiinflammatory phenotype after experimental intracerebral hemorrhage in rats. CNS Neurosci Ther 25:674\u2013684. https:\/\/doi.org\/10.1111\/cns.13100","journal-title":"CNS Neurosci Ther"},{"key":"4560_CR21","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/infdis\/jiz512","volume":"221","author":"Z Wang","year":"2020","unstructured":"Wang Z, Li G, Dou S et al (2020) Tim-3 promotes Listeria monocytogenes Immune Evasion by suppressing Major Histocompatibility Complex Class I. J Infect Dis 221:830\u2013840. https:\/\/doi.org\/10.1093\/infdis\/jiz512","journal-title":"J Infect Dis"},{"key":"4560_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66501","volume":"10","author":"S Dou","year":"2021","unstructured":"Dou S, Li G, Li G et al (2021) Ubiquitination and degradation of NF90 by Tim-3 inhibits antiviral innate immunity. eLife 10:e66501. https:\/\/doi.org\/10.7554\/eLife.66501","journal-title":"eLife"},{"key":"4560_CR23","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun J, Li H, Jin Y et al (2021) Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav Immun 91:703\u2013715. https:\/\/doi.org\/10.1016\/j.bbi.2020.10.014","journal-title":"Brain Behav Immun"},{"key":"4560_CR24","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Ning J, Bao X-Q et al (2021) Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9:226. https:\/\/doi.org\/10.1186\/s40168-021-01107-9","journal-title":"Microbiome"},{"key":"4560_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"M-F Sun","year":"2018","unstructured":"Sun M-F, Zhu Y-L, Zhou Z-L et al (2018) Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav Immun 70:48\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2018.02.005","journal-title":"Brain Behav Immun"},{"key":"4560_CR26","doi-asserted-by":"publisher","unstructured":"Bruns RF, Mitchell SN, Wafford KA et al (2018) Preclinical profile of a dopamine D1 potentiator suggests therapeutic utility in neurological and psychiatric disorders. Neuropharmacology 128. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.10.032","DOI":"10.1016\/j.neuropharm.2017.10.032"},{"key":"4560_CR27","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/aps.2017.49","volume":"38","author":"Q-S Zhang","year":"2017","unstructured":"Zhang Q-S, Heng Y, Mou Z et al (2017) Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease. Acta Pharmacol Sin 38:1317\u20131328. https:\/\/doi.org\/10.1038\/aps.2017.49","journal-title":"Acta Pharmacol Sin"},{"key":"4560_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155230","volume":"123","author":"X-P Yang","year":"2024","unstructured":"Yang X-P, Huang J-H, Ye F-L et al (2024) Echinacoside exerts neuroprotection via suppressing microglial \u03b1-synuclein\/TLR2\/NF-\u03baB\/NLRP3 axis in parkinsonian models. Phytomedicine Int J Phytother Phytopharm 123:155230. https:\/\/doi.org\/10.1016\/j.phymed.2023.155230","journal-title":"Phytomedicine Int J Phytother Phytopharm"},{"key":"4560_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2023.110820","volume":"387","author":"J Huang","year":"2024","unstructured":"Huang J, Zhang X, Yang X et al (2024) Baicalin exerts neuroprotective actions by regulating the Nrf2-NLRP3 axis in toxin-induced models of Parkinson\u2019s disease. Chem Biol Interact 387:110820. https:\/\/doi.org\/10.1016\/j.cbi.2023.110820","journal-title":"Chem Biol Interact"},{"key":"4560_CR30","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C (2021) Parkinson\u2019s disease. Lancet Lond Engl 397:2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X","journal-title":"Lancet Lond Engl"},{"key":"4560_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R et al (2023) Microglia mediated Neuroinflammation in Parkinson\u2019s Disease. Cells 12:1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"4560_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41582-023-00822-1","volume":"19","author":"R Patani","year":"2023","unstructured":"Patani R, Hardingham GE, Liddelow SA (2023) Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration. Nat Rev Neurol 19:395\u2013409. https:\/\/doi.org\/10.1038\/s41582-023-00822-1","journal-title":"Nat Rev Neurol"},{"key":"4560_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12974-022-02410-4","volume":"19","author":"AF Pike","year":"2022","unstructured":"Pike AF, Longhena F, Faustini G et al (2022) Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson\u2019s disease. J Neuroinflammation 19:50. https:\/\/doi.org\/10.1186\/s12974-022-02410-4","journal-title":"J Neuroinflammation"},{"key":"4560_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3233\/JPD-223290","volume":"12","author":"LTN Nguyen","year":"2022","unstructured":"Nguyen LTN, Nguyen HD, Kim YJ et al (2022) Role of NLRP3 inflammasome in Parkinson\u2019s Disease and therapeutic considerations. J Park Dis 12:2117\u20132133. https:\/\/doi.org\/10.3233\/JPD-223290","journal-title":"J Park Dis"},{"key":"4560_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S et al (2021) Targeting Microglial \u03b1-Synuclein\/TLRs\/NF-kappaB\/NLRP3 Inflammasome Axis in Parkinson\u2019s Disease. Front Immunol 12:719807. https:\/\/doi.org\/10.3389\/fimmu.2021.719807","journal-title":"Front Immunol"},{"key":"4560_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107933","volume":"99","author":"L Zhao","year":"2021","unstructured":"Zhao L, Cheng S, Fan L et al (2021) TIM-3: an update on immunotherapy. Int Immunopharmacol 99:107933. https:\/\/doi.org\/10.1016\/j.intimp.2021.107933","journal-title":"Int Immunopharmacol"},{"key":"4560_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3577334","volume":"2023","author":"R Oca\u00f1a-Guzman","year":"2023","unstructured":"Oca\u00f1a-Guzman R, Ramon-Luing LA, Vazquez-Bola\u00f1os LA et al (2023) Tim-3 Is Differentially Expressed during Cell Activation and Interacts with the LSP-1 Protein in Human Macrophages. J Immunol Res 2023:3577334. https:\/\/doi.org\/10.1155\/2023\/3577334","journal-title":"J Immunol Res"},{"key":"4560_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.770402","volume":"12","author":"L Tang","year":"2021","unstructured":"Tang L, Li G, Zheng Y et al (2021) Tim-3 relieves experimental autoimmune encephalomyelitis by suppressing MHC-II. Front Immunol 12:770402. https:\/\/doi.org\/10.3389\/fimmu.2021.770402","journal-title":"Front Immunol"},{"key":"4560_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41420-023-01519-6","volume":"9","author":"P Li","year":"2023","unstructured":"Li P, Li X, Wu W et al (2023) Tim-3 protects against cisplatin nephrotoxicity by inhibiting NF-\u03baB-mediated inflammation. Cell Death Discov 9:218. https:\/\/doi.org\/10.1038\/s41420-023-01519-6","journal-title":"Cell Death Discov"},{"key":"4560_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.intimp.2017.10.023","volume":"53","author":"A Yu","year":"2017","unstructured":"Yu A, Zhang X, Li M et al (2017) Tim-3 enhances brain inflammation by promoting M1 macrophage polarization following intracerebral hemorrhage in mice. Int Immunopharmacol 53:143\u2013148. https:\/\/doi.org\/10.1016\/j.intimp.2017.10.023","journal-title":"Int Immunopharmacol"},{"key":"4560_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.npep.2024.102426","volume":"105","author":"E Ram\u00edrez Hern\u00e1ndez","year":"2024","unstructured":"Ram\u00edrez Hern\u00e1ndez E, Hern\u00e1ndez Zimbr\u00f3n LF, Segura P\u00e9rez E et al (2024) Galectin-9 and Tim-3 are upregulated in response to microglial activation induced by the peptide Amyloid-\u03b2 (25\u201335). Neuropeptides 105:102426. https:\/\/doi.org\/10.1016\/j.npep.2024.102426","journal-title":"Neuropeptides"},{"key":"4560_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.1046992","volume":"15","author":"Q Peng","year":"2022","unstructured":"Peng Q, Zhang G, Guo X et al (2022) Galectin-9\/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson\u2019s disease. Front Mol Neurosci 15:1046992. https:\/\/doi.org\/10.3389\/fnmol.2022.1046992","journal-title":"Front Mol Neurosci"},{"key":"4560_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00229","volume":"7","author":"R Oca\u00f1a-Guzman","year":"2016","unstructured":"Oca\u00f1a-Guzman R, Torre-Bouscoulet L, Sada-Ovalle I (2016) TIM-3 regulates distinct functions in macrophages. Front Immunol 7:229. https:\/\/doi.org\/10.3389\/fimmu.2016.00229","journal-title":"Front Immunol"},{"key":"4560_CR44","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1148536","volume":"318","author":"AC Anderson","year":"2007","unstructured":"Anderson AC, Anderson DE, Bregoli L et al (2007) Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318:1141\u20131143. https:\/\/doi.org\/10.1126\/science.1148536","journal-title":"Science"},{"key":"4560_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbi.2018.12.003","volume":"76","author":"M Campolo","year":"2019","unstructured":"Campolo M, Paterniti I, Siracusa R et al (2019) TLR4 absence reduces neuroinflammation and inflammasome activation in Parkinson\u2019s diseases in vivo model. Brain Behav Immun 76:236\u2013247. https:\/\/doi.org\/10.1016\/j.bbi.2018.12.003","journal-title":"Brain Behav Immun"},{"key":"4560_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/cei.13126","volume":"193","author":"Y Guo","year":"2018","unstructured":"Guo Y, Zhang J, Lai X et al (2018) Tim-3 exacerbates kidney ischaemia\/reperfusion injury through the TLR-4\/NF-\u03baB signalling pathway and an NLR-C4 inflammasome activation. Clin Exp Immunol 193:113\u2013129. https:\/\/doi.org\/10.1111\/cei.13126","journal-title":"Clin Exp Immunol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04560-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04560-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T20:15:57Z","timestamp":1743365757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04560-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,23]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["4560"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04560-3","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,23]]},"assertion":[{"value":"1 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}